Drug Profile
Esterified estrogens (Estratab)
Alternative Names: EstratabLatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator Solvay Pharmaceuticals
- Developer Abbott Laboratories
- Class Estradiol congeners; Hormonal replacements; Oral contraceptives
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Menopausal syndrome
- Market Withdrawal Postmenopausal osteoporosis
Most Recent Events
- 16 Feb 2010 Solvay Pharmaceuticals has been acquired and merged into Abbott Laboratories
- 17 Sep 2003 Withdrawn for Menopausal syndrome in USA (PO)
- 17 Sep 2003 Withdrawn for Postmenopausal osteoporosis (prevention) in USA (PO)